Craig Parker
Chief Executive Officer @ Surrozen
San Francisco, United States
Craig Parker is a Series B investor at Surrozen in San Francisco focused on Medical and Biopharma. Craig Parker is the CEO at Surrozen.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Craig Parker invests in
Stages Craig Parker invests in
Countries Craig Parker invests in
Investment Focus
Industry
- Medical 1 (100%)
- Biopharma 1 (100%)
- Therapeutics 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Gryphon Therapeutics
|
Gryphon Therapeutics is a biopharmaceutical company focused on the development of performance-enhanced protein therapeutics. Its products combine chemically synthesized protein backbones with polyethylene glycols such as molecules to create potent medications. | $26M / Series B / Jan 28, 2002 |
Co-Investors
About Surrozen
Surrozen is a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway. Surrozen is developing tissue-specific antibodies designed to engage the body’s existing biological repair mechanisms with potential application across multiple disease areas, including diseases of the intestine, liver, retina,cornea, lung, kidney, cochlea, skin, pancreas and central nervous system.
Surrozen Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Craig Parker
Chief Executive Officer
|
|||
|
Craig Parker
Chief Executive Officer
|
|||
|
Bill McLeod
Corporate Finance Consultant
|
|||
Calvin Kuo
Co-Founder
|
|||
Claudia Janda
Co-Founder and Senior Scientist
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Craig Parker invest in?
Craig Parker invests primarily in Medical, Biopharma and Therapeutics startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Craig Parker last invest?
The most recent investment recorded for Craig Parker closed in Jan 2002. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
